Skip to main content
. 2014 Feb 21;9(2):e89395. doi: 10.1371/journal.pone.0089395

Table 3. Each gene measurement and lung cancer diagnostic test (LCDT) index in surgically removed, formalin-fixed, paraffin-embedded lung samples (n = 20).

MYC E2F1 CDKN1A LCDT
Benign AVE SD CV AVE SD CV AVE SD CV
SB1 1.5E+4 1.2E+4 0.83 6.7E+2 3.9E+2 0.58 3.6E+4 1.5E+4 0.41 2.8E+2
SB2 2.1E+4 8.6E+3 0.42 1.3E+3 9.6E+2 0.77 5.8E+4 9.5E+3 0.16 4.5E+2
SB3 4.1E+3 4.9E+2 0.12 2.8E+3 1.0E+3 0.35 3.1E+4 2.2E+3 0.07 3.8E+2
SB4 7.4E+3 1.0E+3 0.14 1.5E+3 4.5E+2 0.30 3.0E+4 2.6E+3 0.09 3.6E+2
SB5 1.8E+3 3.1E+2 0.17 1.4E+3 1.7E+2 0.12 1.1E+4 5.7E+2 0.05 2.4E+2
SB6 3.2E+3 5.7E+2 0.18 1.3E+3 2.7E+2 0.20 4.1E+4 1.0E+4 0.25 1.1E+2
SB7 8.1E+3 2.4E+3 0.30 7.5E+3 3.7E+3 0.49 4.0E+4 1.3E+4 0.32 1.5E+3
SB8 9.5E+3 3.1E+3 0.33 1.3E+3 8.5E+2 0.65 5.4E+4 3.2E+3 0.06 2.3E+2
SB9 6.6E+3 1.2E+3 0.18 7.1E+2 4.8E+2 0.69 2.4E+4 7.4E+3 0.31 2.0E+2
SB10 2.7E+4 6.8E+3 0.26 9.5E+2 6.3E+2 0.66 7.6E+4 2.6E+4 0.35 3.3E+2
AVE 0.29 0.48 0.21
Malignant AVE SD CV AVE SD CV AVE SD CV
SM1 1.5E+4 3.8E+3 0.25 6.1E+3 2.7E+3 0.45 5.1E+4 2.3E+4 0.45 1.8E+3
SM2 7.4E+3 1.6E+3 0.22 8.2E+3 2.3E+3 0.28 2.2E+4 5.5E+3 0.25 2.8E+3
SM3 1.2E+4 4.0E+3 0.33 1.2E+3 5.0E+2 0.43 1.6E+4 4.4E+3 0.28 8.9E+2
SM4 1.4E+4 2.7E+3 0.20 1.2E+3 5.2E+2 0.43 4.4E+4 7.7E+3 0.17 3.8E+2
SM5 1.2E+4 3.1E+3 0.26 1.8E+3 3.5E+2 0.20 1.8E+4 5.1E+3 0.29 1.2E+3
SM6 7.7E+3 1.8E+3 0.23 4.2E+3 1.9E+3 0.45 1.9E+4 3.7E+3 0.20 1.7E+3
SM7 9.3E+3 2.9E+3 0.31 2.0E+4 6.4E+3 0.31 5.0E+4 1.7E+4 0.33 3.8E+3
SM8 9.8E+3 3.4E+3 0.35 2.8E+3 1.3E+3 0.47 3.6E+4 1.4E+4 0.39 7.6E+2
SM9 1.3E+4 1.6E+3 0.12 3.2E+3 1.3E+2 0.04 2.6E+4 8.5E+3 0.33 1.7E+3
SM10 1.0E+4 1.9E+3 0.19 2.4E+3 9.9E+2 0.41 2.9E+4 1.1E+4 0.40 8.7E+2
AVE 0.25 0.35 0.31

Note: SB: surgically removed, benign sample. SM: surgically removed, malignant sample. AVE: average. SD: standard deviation. CV: coefficient of variation.